KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxlinear (MXL) Common Equity (2016 - 2025)

Historic Common Equity for Maxlinear (MXL) over the last 17 years, with Q4 2025 value amounting to $451.9 million.

  • Maxlinear's Common Equity fell 1247.15% to $451.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $451.9 million, marking a year-over-year decrease of 1247.15%. This contributed to the annual value of $451.9 million for FY2025, which is 1247.15% down from last year.
  • As of Q4 2025, Maxlinear's Common Equity stood at $451.9 million, which was down 1247.15% from $464.7 million recorded in Q3 2025.
  • Over the past 5 years, Maxlinear's Common Equity peaked at $746.0 million during Q2 2023, and registered a low of $420.8 million during Q1 2021.
  • In the last 5 years, Maxlinear's Common Equity had a median value of $542.4 million in 2022 and averaged $564.3 million.
  • Its Common Equity has fluctuated over the past 5 years, first soared by 3907.69% in 2023, then plummeted by 2476.91% in 2024.
  • Quarter analysis of 5 years shows Maxlinear's Common Equity stood at $489.2 million in 2021, then skyrocketed by 38.26% to $676.4 million in 2022, then rose by 1.46% to $686.3 million in 2023, then dropped by 24.77% to $516.3 million in 2024, then dropped by 12.47% to $451.9 million in 2025.
  • Its Common Equity stands at $451.9 million for Q4 2025, versus $464.7 million for Q3 2025 and $488.3 million for Q2 2025.